Eivind Hovig

Cytowane przez

	Wszystkie	Od 2017
Cytowania	15153	5551
h-indeks	56	30
i10-indeks	160	97

1200

600

300

900

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202247 78 105 101 157 238 334 295 320 363 403 419 474 485 549 548 519 488 498 451 426 460 518 513 647 682 840 930 1120 1199 749

Dostęp publiczny

Wyświetl wszystko

64 artykuły

1 artykuł

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Ola MyklebostProfessor Cancer Biology, University of BergenZweryfikowany adres z uib.no
Leonardo A. Meza-ZepedaDepartment Head, Institute for Cancer Research, Oslo University HospitalZweryfikowany adres z rr-research.no
Geir Kjetil SandveProfessor, bioinformatics, University of OsloZweryfikowany adres z ifi.uio.no
Sigve NakkenScientist, Institute for Cancer Research, Oslo University Hospital, NorwayZweryfikowany adres z ifi.uio.no
Bastian FrommThe Arctic University Museum of Norway, UiT The Arctic University of NorwayZweryfikowany adres z uit.no
Trevor ClancyChief Scientific Officer & co-founder at NEC OncoImmunityZweryfikowany adres z oncoimmunity.com
Marit HoldenChief research scientist, Norsk Regnesentral Zweryfikowany adres z nr.no
Sveinung GundersenSenior Engineer, Centre for Bioinformatics, University of OsloZweryfikowany adres z ifi.uio.no
Winston Patrick Kuo, DDS, SM, DMScHarvard UniversityZweryfikowany adres z genetics.med.harvard.edu
Thierry soussiProfessor of Molecular BiologyZweryfikowany adres z ki.se
Marc GreenblattAssociate Professor of Medicine, University of VermontZweryfikowany adres z vtmednet.org
Arnoldo FrigessiUniversity of OsloZweryfikowany adres z medisin.uio.no
Ingrid Kristine GladProfessor of Statistics, University of OsloZweryfikowany adres z math.uio.no
Jonas PaulsenAssociate Professor, University of Oslo, NorwayZweryfikowany adres z ifi.uio.no
Kevin J. PetersonDartmouth CollegeZweryfikowany adres z dartmouth.edu
Kjetil BoyeOslo University HospitalZweryfikowany adres z rr-research.no
Åke BorgDepartment of Oncology, Clinical Sciences, Lund University, SwedenZweryfikowany adres z med.lu.se
Lars HoldenMan. dir. Norsk RegnesentralZweryfikowany adres z nr.no
Ståle NygårdCancer Registry of NorwayZweryfikowany adres z kreftregisteret.no
Mette LangaasDepartment of Mathematical Sciences, Norwegian University of Science and TechnologyZweryfikowany adres z ntnu.no

Obserwuj

Eivind Hovig

Professor.1. Centre for bioinformatics. Dept. of Informatics, Univ of Oslo. 2. Oslo Univ. Hosp.

Zweryfikowany adres z ifi.uio.no

Cancer genomics DNA variation bioinformatics


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Database of p53 gene somatic mutations in human tumors and cell lines. M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ... Nucleic acids research 22 (17), 3551, 1994	1311	1994
A literature network of human genes for high-throughput analysis of gene expression TK Jenssen, A Lægreid, J Komorowski, E Hovig Nature genetics 28 (1), 21-28, 2001	1095	2001
Ten simple rules for reproducible computational research GK Sandve, A Nekrutenko, J Taylor, E Hovig PLoS computational biology 9 (10), e1003285, 2013	682	2013
Somatic Point Mutations in the p53 Gene of Human Tumors and Cell Lines: Updated Compilation M Hollstein, B Shomer, M Greenblatt, T Soussi, E Hovig, R Montesano, ... Nucleic acids research 24 (1), 141-146, 1996	662	1996
A uniform system for the annotation of human microRNA genes and the evolution of the human microRNAome B Fromm, T Billipp, LE Peck, M Johansen, JE Tarver, BL King, ... Annual review of genetics 49, 213, 2015	457	2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 66 (3), 464-472, 2017	415	2017
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects P Hainaut, T Soussi, B Shomer, M Hollstein, M Greenblatt, E Hovig, ... Nucleic acids research 25 (1), 151-157, 1997	393	1997
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ... Gut 67 (7), 1306-1316, 2018	391	2018
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ... Nature communications 6 (1), 1-13, 2015	271	2015
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020	256	2020
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. AL Børresen, E Hovig, B Smith-Sørensen, D Malkin, S Lystad, ... Proceedings of the National Academy of Sciences 88 (19), 8405-8409, 1991	251	1991
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma GM Maelandsmo, VA Flørenes, T Mellingsaeter, E Hovig, RS Kerbel, ... International journal of cancer 74 (4), 464-469, 1997	244	1997
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells P Ruud, Ø Fodstad, E Hovig International journal of cancer 80 (1), 119-125, 1999	242	1999
Screening for Germ Line TP53 Mutations in Breast Cancer Patients AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ... Cancer research 52 (11), 3234-3236, 1992	242	1992
Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses V Nygaard, EA Rødland, E Hovig Biostatistics 17 (1), 29-39, 2016	230	2016
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti … K Bjørnland, JO Winberg, OT Ødegaard, E Hovig, T Loennechen, ... Cancer research 59 (18), 4702-4708, 1999	218	1999
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ... Genes, Chromosomes and Cancer 14 (1), 71-75, 1995	213	1995
Performance comparison of four exome capture systems for deep sequencing CSR Chilamakuri, S Lorenz, MA Madoui, D Vodák, J Sun, E Hovig, ... BMC genomics 15 (1), 1-14, 2014	191	2014
A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies WP Kuo, F Liu, J Trimarchi, C Punzo, M Lombardi, J Sarang, ME Whipple, ... Nature biotechnology 24 (7), 832-840, 2006	188	2006
p53 Abnormalities in Different Subtypes of Human Sarcomas Å Andreassen, T Øyjord, E Hovig, R Holm, VA Flørenes, JM Nesland, ... Cancer research 53 (3), 468-471, 1993	177	1993

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy